Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Semaglutide. | Image Credit: K KStock - stock.adobe.com

Semaglutide Linked to Lower Dementia Risk in Type 2 Diabetes

By Pearl Steinzor

June 24th 2025

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared with other diabetes drugs.

Type 2 diabetes - greenapple78 - stock.adobe.com

Previsit Tools Boost Diabetes Deprescribing in Older Adults, Study Finds

By Pearl Steinzor

June 23rd 2025

Diabetic man | Image credit: Krakenimages.com - stock.adobecom

Addressing Barriers to Hispanic Men's Engagement in Diabetes Prevention

By Pearl Steinzor

June 18th 2025

Liver disease | Image credit: Crystal light - stock.adobe.com

Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

By Pearl Steinzor

June 13th 2025

DASH diet | Image credit: Albi - stock.adobe.com

DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

By Pearl Steinzor

June 10th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background

Continuing Medical Education

June 28th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

June 28th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

March 4th 2017

A Bundle of Nudges: Healthcare Payment in an Era of Behavioral Science

Mike Payne, MBA, MSci

Using digital health to manage chronic disease means creating new payment models that recognize care is an ongoing process.

March 4th 2017

Reaching Beyond the Exam Room: How Technology-backed Lifestyle Intervention Is Improving Health Outcomes for Diabetes and Hypertension Management

Andreas Michaelides, PhD Ed Pienkosz, MS

Authors from the digital health provider Noom offer an update of a successful employer-based initiative.

March 3rd 2017

Can Yoga, Mindfulness Fit With Managed Care?

Recent studies have linked yoga and mindfulness with reduced stress, improved glycemic control, and even lower medical costs. Should these low-cost practices find ways to standardize to meet payers' needs? Or is it managed care that needs to adapt?

March 3rd 2017

Diabetes: An Opportunity to Have a Lasting Impact on Health Through Lifestyle Modification

Hena N. Patel, MD Andrew M. Freeman, MD, FACC Kim A. Williams MD, FACC

Three cardiologists, including the 2015-2016 president of the American College of Cardiology, review the evidence in support of lifestyle modification for diabetes management or remission.

March 3rd 2017

Neediest Diabetes Patients Can Benefit Most From Health Coaching Initiatives

Christina Mattina

Health coaching for diabetes patients increased diabetes knowledge in all participants, but the most significant clinical improvements were seen in those who had been faring poorly at baseline, according to the newly published results of a chronic disease management program in Australia

March 2nd 2017

Differential Weight Loss Effects on Type 2 Diabetes Remission Among Adults

Virender Kumar, PhD William Encinosa, PhD Hena Thakur Kisha Thakur

An analysis of nationally representative survey-based data finds that 5.2% of adults with type 2 diabetes were in remission, without bariatric surgery, at the end of the second year.

March 2nd 2017

From the Editor in Chief: Why WAIT Results Highlight the Value of Lifestyle Intervention

Robert A. Gabbay, MD, PhD, FACP

Five-year results of the Why WAIT study at Joslin Diabetes Center.

March 1st 2017

Being Active May Counter Effects of Obesity on Cardiovascular Disease

US and European guidelines recommend 150 minutes per week of moderate physical activity.

February 28th 2017

Diabetes Prevented in 80% of At-Risk Patients Taking Liraglutide

The study points to an additional tool that could help prevent at-risk patients from progressing to diabetes.

February 27th 2017

Measuring Cortisol Levels in Hair Shows Link Between Stress, Obesity

For some time, studies have shown a link between elevated stress and obesity. Measuring cortisol levels in the hair may be a better way to evaluate chronic stress, since the hormone level will not fluctuate from day to day.

Dr Yehuda Handelsman Discusses New Alternatives to Basal Insulin

February 27th 2017

Dr Yehuda Handelsman Discusses New Alternatives to Basal Insulin

Recent advances in insulin formulations and innovative drug classes have made it easier than ever to manage diabetic patients’ glucose levels, according to Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

This Week in Managed Care: February 24, 2017

February 24th 2017

This Week in Managed Care: February 24, 2017

This week, the top managed care stories included Republicans releasing an outline for replacing the Affordable Care Act, pharmacy benefit managers and pharmaceutical companies pointing fingers over drug costs, and findings on engagement for patients with chronic conditions.

February 24th 2017

Busier Docs Provide Lower-Quality Diabetes Care, Unless They Treat Many Diabetics

Christina Mattina

Patients treated by primary care providers with a high volume of patients experienced worse management of their disease. However, if a physician specifically treated a higher number of diabetics, the quality of the diabetes care received by patients was significantly higher.

February 23rd 2017

CDC: Poorest Seniors More Likely to Have Multiple Chronic Conditions

The results are important given the concentration of Medicare beneficiaries who are in Medicaid and being treated for multiple chronic conditions.

February 23rd 2017

Heart Risks at Midlife Signal Dementia Down the Road

The study adds to the growing body of evidence linking heart disease and diabetes to dementia.

February 22nd 2017

Tailoring Diabetes Coaching to Patients Trims Hospital Visits

As health plans ramp up efforts to “coach” patients with diabetes and other chronic diseases, a study in The American Journal of Managed CareÂ® finds that customizing these efforts to patients’ knowledge and needs reduces hospital visits and improves some health measures.

February 22nd 2017

Collaborative Care Offers Help for Seniors With Mild Depression, Study Finds

The results from the United Kingdom support CMS' decision to add a payment code for collaborative care to this year's Medicare Physician Fee Schedule.

February 21st 2017

When It Comes to Seeking Healthcare, Money Changes Everything

The results follow a separate report that outlined the reasons why low-income workers don't seek preventive care, and what can be done.

February 21st 2017

Diabetes Prevention Updates: Omada Health's New Hire; ACPM Announces Grant Winners

The announcements come as Medicare is set to start reimbursing the Diabetes Prevention Program on January 1, 2018.

February 20th 2017

Comparing Surgery, Medication for Type 2 Diabetes in Overweight Patients

This small study found sustained weight loss of 10% of body weight in patients who were overweight but not obese, along with improvements in glycemic control and quality of life that exceeded patients taking medication only.

February 17th 2017

High-Deductible Plans Discouraged Visits by Low-Income Diabetes Patients

Christina Mattina

A study in Diabetes Care examined the effects of high-deductible health plans on healthcare utilization for diabetes patients with varying incomes.

This Week in Managed Care: February 17, 2017

February 17th 2017

This Week in Managed Care: February 17, 2017

This week, the top managed care stories included the end of 2 insurance megamergers, a proposed rule to tighten restrictions for the Affordable Care Act, and new legislation in New Jersey provides the nation's strictest mandates for treating addiction.

February 16th 2017

"Footprints" Help Scientists Get Warmer on Personalized Diabetes Care

Researchers examined how genetic variants linked to type 2 diabetes behave in their environment, and the results pointed to a molecule that affects how pancreatic islet cells "read" the genes.

February 15th 2017

In Light of SPRINT, How to Treat Hypertension?

An author in JAMA points out some caveats to a ground-breaking trial.

February 15th 2017

Economic Burden of Hypoglycemia With Basal Insulin in Type 2 Diabetes

Vivian Fonseca, MD Engels Chou, MS Hsing-Wen Chung, PhD Charles Gerrits, PhD, PharmD

Hypoglycemia after basal insulin initiation is associated with high clinical and economic burden that precedes insulin initiation and persists during 1 to 2 years of follow-up.

February 14th 2017

FDA Issues Alert About Fluid-Filled Balloons to Treat Obesity

So far, the adverse events have been reported for the 2 fluid-filled designs, not for an air-filed design later approved.

February 13th 2017

Trial Results Published for Medtronic's MiniMed 670G

Results show how the hybrid closed loop system reduced glycemic variability, which leads to fewer long-term complications from type 1 disease.

February 12th 2017

Low Socioeconomic Status Linked to Reduced Life Expectancy

Laura Joszt, MA

An analysis of 1.7 million men and women found that low socioeconomic status is linked to a reduction in life expectancy of 2.1 years between the ages of 40 and 85.

Podcast: This Week in Managed Care - Drop in ACA Enrollment, and Other News

February 11th 2017

Podcast: This Week in Managed Care - Drop in ACA Enrollment, and Other News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

February 10th 2017

Praluent to Stay on Market as PCSK9 Patent War Continues in Court

Attorneys for Sanofi, a sponsor of Praluent, said the public interest in having more than one drug available in the PCSK9 class would be an important part of their claim.

...

44 45 46 47 48 49 50 51 52

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions